Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of aLdosterone Inhibition by baXdrostat on Molecular Imaging of cytoReduction in Primary Aldosteronism and Hypertension

NCT07800858 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT07800858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07800858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of aLdosterone Inhibition by baXdrostat on Molecular Imaging of cytoReduction in Primary Aldosteronism and Hypertension
Lead sponsor
Queen Mary University of London
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 15, 2026
Completion date
May 31, 2028
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism